FDA Inspection 1204992 — Analys Lab Private Limited

Analys Lab Private Limited — FEI 3013495798

The FDA completed an inspection of Analys Lab Private Limited on April 14, 2023 in Secunderabad. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 14, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Secunderabad (India)